409 related articles for article (PubMed ID: 10446376)
1. Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline.
Kovarik Z; Radić Z; Grgas B; Skrinjarić-Spoljar M; Reiner E; Simeon-Rudolf V
Biochim Biophys Acta; 1999 Aug; 1433(1-2):261-71. PubMed ID: 10446376
[TBL] [Abstract][Full Text] [Related]
2. Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.
Bosak A; Gazić I; Vinković V; Kovarik Z
Arch Biochem Biophys; 2008 Mar; 471(1):72-6. PubMed ID: 18167304
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective inhibition of human, mouse, and horse cholinesterases by bambuterol enantiomers.
Bosak A; Gazić I; Vinković V; Kovarik Z
Chem Biol Interact; 2008 Sep; 175(1-3):192-5. PubMed ID: 18582854
[TBL] [Abstract][Full Text] [Related]
4. Interaction of human butyrylcholinesterase variants with bambuterol and terbutaline.
Kovarik Z; Simeon-Rudolf V
J Enzyme Inhib Med Chem; 2004 Apr; 19(2):113-7. PubMed ID: 15449725
[TBL] [Abstract][Full Text] [Related]
5. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
[TBL] [Abstract][Full Text] [Related]
6. Effects of acetylcholinesterase and butyrylcholinesterase inhibition on breathing in mice adapted or not to reduced acetylcholinesterase.
Boudinot E; Taysse L; Daulon S; Chatonnet A; Champagnat J; Foutz AS
Pharmacol Biochem Behav; 2005 Jan; 80(1):53-61. PubMed ID: 15652380
[TBL] [Abstract][Full Text] [Related]
7. Peripheral site and acyl pocket define selective inhibition of mouse butyrylcholinesterase by two biscarbamates.
Bosak A; Smilović IG; Stimac A; Vinković V; Sinko G; Kovarik Z
Arch Biochem Biophys; 2013 Jan; 529(2):140-5. PubMed ID: 23219600
[TBL] [Abstract][Full Text] [Related]
8. Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochem J; 2003 Jul; 373(Pt 1):33-40. PubMed ID: 12665427
[TBL] [Abstract][Full Text] [Related]
9. Bambuterol, a carbamate ester prodrug of terbutaline, as inhibitor of cholinesterases in human blood.
Tunek A; Svensson LA
Drug Metab Dispos; 1988; 16(5):759-64. PubMed ID: 2906603
[TBL] [Abstract][Full Text] [Related]
10. Reversible inhibition of acetylcholinesterase and butyrylcholinesterase by 4,4'-bipyridine and by a coumarin derivative.
Simeon-Rudolf V; Kovarik Z; Radić Z; Reiner E
Chem Biol Interact; 1999 May; 119-120():119-28. PubMed ID: 10421445
[TBL] [Abstract][Full Text] [Related]
11. Metaproterenol, isoproterenol, and their bisdimethylcarbamate derivatives as human cholinesterase inhibitors.
Bosak A; Gazić Smilović I; Sinko G; Vinković V; Kovarik Z
J Med Chem; 2012 Aug; 55(15):6716-23. PubMed ID: 22817559
[TBL] [Abstract][Full Text] [Related]
12. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
Kandasamy S; Loganathan C; Sakayanathan P; Karthikeyan S; Stephen AD; Marimuthu DK; Ravichandran S; Sivalingam V; Thayumanavan P
Int J Biol Macromol; 2021 Aug; 185():750-760. PubMed ID: 34216669
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel carbamates as potential inhibitors of acetylcholinesterase and butyrylcholinesterase.
Wu J; Pistolozzi M; Liu S; Tan W
Bioorg Med Chem; 2020 Mar; 28(5):115324. PubMed ID: 32008882
[TBL] [Abstract][Full Text] [Related]
14. Stereoselective inhibition of human butyrylcholinesterase by the enantiomers of bambuterol and their intermediates.
Pistolozzi M; Du H; Wei H; Tan W
Drug Metab Dispos; 2015 Mar; 43(3):344-52. PubMed ID: 25504505
[TBL] [Abstract][Full Text] [Related]
15. Molecular dissection of cholinesterase domains responsible for carbamate toxicity.
Loewenstein Y; Denarie M; Zakut H; Soreq H
Chem Biol Interact; 1993 Jun; 87(1-3):209-16. PubMed ID: 8343977
[TBL] [Abstract][Full Text] [Related]
16. Identification of Compounds for Butyrylcholinesterase Inhibition.
Li S; Li AJ; Travers J; Xu T; Sakamuru S; Klumpp-Thomas C; Huang R; Xia M
SLAS Discov; 2021 Dec; 26(10):1355-1364. PubMed ID: 34269114
[TBL] [Abstract][Full Text] [Related]
17. Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
Chem Biol Interact; 1999 May; 119-120():61-9. PubMed ID: 10421439
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of acetylcholinesterase and butyrylcholinesterase by chlorpyrifos-oxon.
Amitai G; Moorad D; Adani R; Doctor BP
Biochem Pharmacol; 1998 Aug; 56(3):293-9. PubMed ID: 9744565
[TBL] [Abstract][Full Text] [Related]
19. Rivastigmine-Bambuterol Hybrids as Selective Butyrylcholinesterase Inhibitors.
Wu J; Tan Z; Pistolozzi M; Tan W
Molecules; 2023 Dec; 29(1):. PubMed ID: 38202655
[TBL] [Abstract][Full Text] [Related]
20. Proline-Based Carbamates as Cholinesterase Inhibitors.
Pizova H; Havelkova M; Stepankova S; Bak A; Kauerova T; Kozik V; Oravec M; Imramovsky A; Kollar P; Bobal P; Jampilek J
Molecules; 2017 Nov; 22(11):. PubMed ID: 29135926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
